Showing 1629 companies
Company Headquarters: New Jersey, US Founded: 1998 Workforce: ~25 Company Working: Elusys Therapeutics, Inc. is a commercial-stage biopharmaceutical company that develops antibody-based products to treat infectious diseases. It has partnerships with renowned biodefense associations, including the Centers for Disease Control and Prevention (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), and the National Institute of Allergy and Infectious Diseases (US). It supplies its anthrax antitoxin products from the Strategic National Stockpile (US). Moreover, it is a wholly owned subsidiary of NightHawk Biosciences (US) and is expanding NightHawk's biodefense space while also complementing NightHawk’s RapidVax platform, which is designed to specifically target emerging biological threats
Company Headquarters: California, US Founded: 1996 Workforce: ~351 Company Working: Dynavax Technologies is a commercial-stage biopharmaceutical business with extensive experience and skill in vaccine development and commercialization. The company has established several clinical and preclinical collaborations with vaccine developers to evaluate vaccine product candidates against influenza, other infectious diseases, and particularly COVID-19 across a variety of vaccine platforms. It is focused on building an innovative pipeline of investigational vaccine product candidates, leveraging its proven, proprietary vaccine adjuvant technology
Company Headquarters: Maryland, US Founded: 1998 Workforce: ~2,500 Company Working: Emergent is a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats (PHTs). Its solutions include product portfolio, products that are under development (pipeline products), and contract development and manufacturing (“CDMO”). Revenues are generated by the sale and procurement of the company's product/product candidate portfolio, the provision of CDMO services to external customers, and non-dilutive contract and grant funding for research and development ("R&D") projects from various third-party sources
Unlock Verified Contacts
Access verified employee contacts
Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence